Research Papers

25 of 176 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Therapeutic effects of minocycline on oleic acid-induced acute respiratory distress syndrome (ARDS) in rats.
Ghasemzadeh Rahbardar M; Razavi BM; Naraki K; Hosseinzadeh H.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms.
Molderings GJ; Afrin LB.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Tiagabine and zonisamide differentially regulate the glial properties in an astrocyte-microglia co-culture model of inf…
Ismail FS; Faustmann PM; Förster E; Corvace F; Faustmann TJ.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A highlight on carbamazepine-induced adverse drug reactions in Saudi Arabia: a retrospective medical records-based stud…
Sukkarieh HH; Khokhar AA; Bustami RT; Karbani GA; Alturki FA; Alvi SN.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
2/6 Transparent
Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells.
Zheng J; Gong S; Wu G; Zheng X; Li J; Nie J; Liu Y; Chen B; Liu Y; Su Z; Chen J; Li Y.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell-derived spheres.
Fu Y; Dong W; Xu Y; Li L; Yu X; Pang Y; Chan L; Deng Y; Qian C.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.
Friebe A; Kraehling JR; Russwurm M; Sandner P; Schmidtko A.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Implications of BCRP modulation on PTZ-induced seizures in mice: Role of ko143 and metformin as adjuvants to lamotrigin…
Harby SA; Khalil NA; El-Sayed NS; Thabet EH; Saleh SR; Fathelbab MH.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Critical analysis of the prescription and evaluation of protein kinase inhibitors for oncology in Germany.
Obst CS; Seifert R.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Metformin mitigates radiation toxicity exerting antioxidant and genoprotective properties.
Karmanova EE; Chernikov AV; Popova NR; Sharapov MG; Ivanov VE; Bruskov VI.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focu…
Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A review of the bioactive components and pharmacological properties of Lavandula species.
Batiha GE; Teibo JO; Wasef L; Shaheen HM; Akomolafe AP; Teibo TKA; Al-Kuraishy HM; Al-Garbeeb AI; Alexiou A; Papadakis M.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected.
Ferrara F; Zovi A; Masi M; Langella R; Trama U; Boccellino M; Vitiello A.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bronchitis, COPD, and pneumonia after viral endemic of patients with leprosy on Sorok Island in South Korea.
Lee JH; Kanwar B; Khattak A; Altschuler E; Sergi C; Lee SJ; Choi SH; Park J; Coleman M; Bourbeau J.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Data
Cardiovascular effects of bufotenin on human 5-HT<sub>4</sub> serotonin receptors in cardiac preparations of transgenic…
Neumann J; Schulz N; Fehse C; Azatsian K; Čináková A; Marušáková M; Hofmann B; Gergs U.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation.
Hu J; Xu J; Tan X; Li D; Yao D; Xu B; Lei Y.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Increase of c-FOS promoter transcriptional activity by the dual leucine zipper kinase.
Köster KA; Duque Escobar J; Fietkau A; Toledo R; Oetjen E.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in …
Dulf PL; Mocan M; Coadă CA; Dulf DV; Moldovan R; Baldea I; Farcas AD; Blendea D; Filip AG.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Methodological and reporting quality evaluation of Buyang Huanwu decoction for experimental cerebral ischemia-reperfusi…
Chen X; Yang T; Luo Y; Feng Z; Fang R; Ge J; Mei Z.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Revisiting the therapeutic potential of gingerols against different pharmacological activities.
Sharma S; Shukla MK; Sharma KC; Tirath; Kumar L; Anal JMH; Upadhyay SK; Bhattacharyya S; Kumar D.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2022
2/6 Transparent
Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review …
Zaazouee MS; Eleisawy M; Abdalalaziz AM; Elhady MM; Ali OA; Abdelbari TM; Hasan SM; Almadhoon HW; Ahmed AY; Fassad AS; Elgendy R; Abdel-Baset EA; Elsayed HA; Elsnhory AB; Abdraboh AB; Faragalla HM; Elshanbary AA; Kensara OA; Abdel-Daim MM.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Ameliorative effects of quercetin against hepatic toxicity of oral sub-chronic co-exposure to aluminum oxide nanopartic…
Abo-El-Sooud K; Abd-Elhakim YM; Hashem MMM; El-Metwally AE; Hassan BA; El-Nour HHM.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carci…
Mohamed MF; Ibrahim NS; Saddiq AA; Almaghrabi OA; Al-Hazemi ME; Hassaneen HM; Abdelhamid IA.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Abella LMR; Hoffmann R; Neumann J; Hofmann B; Gergs U.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP<sub>2</sub> binding.
Xynogalos P; Rahm AK; Fried S; Chasan S; Scherer D; Seyler C; Katus HA; Frey N; Zitron E.
Naunyn Schmiedebergs Arch Pharmacol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared